A preliminary pharmacokinetic study of docetaxel, carboplatin and concurrent radiotherapy for regionally advanced squamous cell carcinoma of the head and neck

Farmaco

Volumn 56, Issue 9, 2001, Pages 695-699

  Cattel, Luigi ^a   Recalenda, Valeria ^a   Airoldi, Mario ^b   Tagini, Valentina ^a   Delprino, Laura ^a   Rocco, Flavio ^a   Bumma, Cesare ^b  

^a Dipartimento di Scienza e Tecnologia del Farmaco   (Turkey)

^b Divisione di Oncologia Medica ASL1   (Turkey)

Author keywords

Carboplatin; Docetaxel; Head and neck cancer; Pharmacokinetics; Radiotherapy; Toxicity

Indexed keywords

CARBOPLATIN; DEXAMETHASONE; DOCETAXEL; ITRACONAZOLE; METOCLOPRAMIDE;

ADVANCED CANCER; AREA UNDER THE CURVE; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; DRUG BLOOD LEVEL; DRUG DISTRIBUTION; DRUG ELIMINATION; DRUG HALF LIFE; HEAD AND NECK CARCINOMA; MUCOSA INFLAMMATION; NONHUMAN; PHARMACOKINETICS; SQUAMOUS CELL CARCINOMA; THROMBOCYTOPENIA;

ANTINEOPLASTIC AGENTS; AREA UNDER CURVE; CARBOPLATIN; CARCINOMA, SQUAMOUS CELL; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; COMBINED MODALITY THERAPY; HALF-LIFE; HEAD AND NECK NEOPLASMS; HUMANS; INFUSIONS, INTRAVENOUS; PACLITAXEL; TAXOIDS;

EID: 0035415919     PISSN: 0014827X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-827X(01)01137-5     Document Type: Article

References (27)

1. Carboplatin (NSC-241-240): an active platinum analog for the treatment of squamous-cell carcinoma of the head and neck
2. Carboplatin: a very active new cisplatin analog in the treatment of small cell lung cancer
3. Pharmacokinetics and dosage reduction of cis-diammine(1,1-cyclobutanedicarboxylato)platinum in patients with impaired renal function
4. Dose optimisation of carboplatin in adults
5. Mechanism of action of taxol
6. The development and clinical utility of the taxane class of antimicrotubule chemotherapy agents
7. Docetaxel (Taxotere) in combination with platinum-based regimens in non-small cell lung cancer: results and future developments
8. Continuous infusion of carboplatin during conventional radiotherapy treatment in advanced squamous carcinoma of the cervix uteri IIB-IIIB (UICC)
9. Concomitant radiotherapy and daily low-dose carboplatin in locally advanced, unresectable head and neck cancer
10. Enhancement of radiation effects by combined docetaxel and carboplatin treatment in vitro
11. Carboplatin-paclitaxel- and carboplatin-docetaxel-induced cytotoxic effect in epithelial ovarian carcinoma in vitro
12. Weekly docetaxel and concomitant boost radiotherapy for non-small cell lung cancer. A phase I/II dose escalation trial
13. Phase I study of Docetaxel with concomitant thoracic radiation therapy
14. Validated method for the determination of carboplatin in biological fluids by Zeeman atomic absorption spectrometry
15. Docetaxel in combination with epirubicin in metastatic breast cancer: pharmacokinetic interactions
16. Pharmacokinetics of unchanged carboplatin (CBCDA) in patients with small cell lung carcinoma
17. Dose-finding and sequencing study of paclitaxel and carboplatin in non-small cell lung cancer
18. Pharmacokinetics and metabolism of docetaxel administered as a 1-h intravenous infusion
19. Prediction of carboplatin clearance from standard morphological and biological patient characteristics
20. Clinical pharmacokinetics of carboplatin
21. Phase I pharmacokinetic study of multicycle high-dose carboplatin followed by peripheral-blood stem-cell infusion in patients with cancer
22. A phase I and pharmacokinetics study of prolonged ambulatory-infusion carboplatin
23. Pharmacokinetics of cis-diammine-1,1-cyclobutane dicarboxylate platinum(II) in patients with normal and impaired renal function
24. Phase I and pharmacokinetic study of taxotere (RP 56976; NSC 628503) given as a short intravenous infusion
25. Reduced ability to clear ultrafilterable platinum with repeated courses of cisplatin
26. A review of the pharmacokinetics and pharmacodynamics of combination carboplatin/paclitaxel
27. Clinical pharmacokinetics of carboplatin in children